Two Years versus One Year of Tianjiu Therapy in Sanfu Days for Chronic Asthma: A Clinical Efficacy Observation Trial

Table 1

Baseline characteristics of study participants.

Characteristic	Tianjiu Therapy ()
Age—year	50.35 ± 17.17
Gender—number (%)
Male	48 (47.1)
Female	54 (52.9)
Duration of asthma—year	20.22 ± 14.14
Asthma-related symptoms—number of^a	9.35 ± 11.90
Lung function
FEV1	1.86 ± 0.98
FEV1:FVC × 100	85.24 ± 27.76
Asthma-related health care—number (%)
≥1 Admitted to A and E^b	23 (22.5)
≥1 Hospitalization	19 (18.6)
≥1 Outpatient visit	60 (58.8)
≥1 Prescription	72 (70.6)
≥1 Buy medication	11 (10.8)
≥1 Not to be processed	10 (9.8)
The frequency of bronchodilator used during asthma attack—number (%)
More than twice per day	25 (24.5)
Once to twice per day	38 (37.3)
2-3 times per week	5 (4.9)
Less than once per week	16 (15.7)
Never	18 (17.6)
Symptoms which frequently appeared in asthma patients—number of symptoms^c	8.20 ± 4.40

Plus-minus values are means ± SD, unless noted otherwise. PIF denotes peak inspiratory flow; PEF: peak expiratory flow; FEV₁: forced expiratory volume in one second; FVC: forced vital capacity.
^bThe total number of symptoms which frequently appeared in asthma patients is 23 and its scale ranges from 0 to 23.
^cAccident and Emergency Departments (A and E).